EdwardLewisTobinickMD

PubMed

• 2 citations
  Immediate Resolution of Hemispatial Neglect and Central Post-Stroke Pain After Perispinal Etanercept: Case Report
  Edward L Tobinick> ;Clinical Drug Investigation. 2020 Jan 1
• 5 citations
  Perispinal injection of a TNF blocker directed to the brain of rats alleviates the sensory and affective components of chronic constriction injury-induced neuropathic ...
  Zach LaMacchia, Robert N. Spengler, Muhammad Jaffari, Asif H. Abidi, Tariq Ahmed, Natasha Singh, Edward L Tobinick, Tracey A. Ignatowski> ;Brain Behavior and Immunity. 2019 Nov 1
• 6 citations
  Perispinal etanercept advances as a neurotherapeutic.
  Edward L Tobinick> ;Expert Review of Neurotherapeutics. 2018 Apr 25
• 10 citations
  Perispinal Delivery of CNS Drugs
  Edward L Tobinick> ;CNS Drugs. 2016 Apr 27
• 5 citations
  Authors' reply to Whitlock: Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidence.
  Tracey A. Ignatowski, Robert N. Spengler, Edward L Tobinick> ;CNS Drugs. 2014 Nov 6
• 22 citations
  Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidence.
  Tracey A. Ignatowski, Robert N. Spengler, Krishnan M. Dhandapani, Hedy Folkersma, Roger F. Butterworth, Edward L Tobinick> ;CNS Drugs. 2014 May 27
• 21 citations
  Immediate Neurological Recovery Following Perispinal Etanercept Years After Brain Injury
  Edward L Tobinick, Helen Rodriguez-Romanacce, Arthur Levine, Tracey A. Ignatowski, Robert N. Spengler> ;Clinical Drug Investigation. 2014 Mar 20
• 1 citations
  Author’s Reply to Page: “Selective TNF Inhibition for Chronic Stroke and Traumatic Brain Injury: An Observational Study Involving 629 Consecutive Patients Treated with...
  Edward L Tobinick> ;CNS Drugs. 2013 Apr 12
• 65 citations
  Selective TNF Inhibition for Chronic Stroke and Traumatic Brain Injury
  Edward L Tobinick, Nancy M. Kim, Gary Reyzin, Helen Rodriguez-Romanacce, Venita DePuy> ;CNS Drugs. 2012 Oct 26
• 17 citations
  Deciphering the Physiology Underlying the Rapid Clinical Effects of Perispinal Etanercept in Alzheimer's Disease
  Edward L Tobinick> ;Current Alzheimer Research. 2012 Jan 1
• 29 citations
  Rapid improvement of chronic stroke deficits after perispinal etanercept: three consecutive cases.
  Edward L Tobinick> ;CNS Drugs. 2011 Feb 1
• 36 citations
  Perispinal etanercept: a new therapeutic paradigm in neurology
  Edward L Tobinick> ;Expert Review of Neurotherapeutics. 2010 Jun 1
• 65 citations
  Tumour Necrosis Factor Modulation for Treatment of Alzheimer’s Disease
  Edward L Tobinick> ;CNS Drugs. 2009 Sep 1
• 106 citations
  The value of drug repositioning in the current pharmaceutical market.
  Edward L Tobinick> ;Drug News & Perspectives. 2009 Mar 1
• 23 citations
  Rapid intracerebroventricular delivery of Cu-DOTA-etanercept after peripheral administration demonstrated by PET imaging
  Edward L Tobinick, Kai Chen, Xiaoyuan Chen> ;BMC Research Notes. 2009 Feb 27
• 29 citations
  Perispinal etanercept for neuroinflammatory disorders.
  Edward L Tobinick> ;Drug Discovery Today. 2009 Feb 1
• 59 citations
  Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer's disease.
  Edward L Tobinick, Hyman Gross> ;BMC Neurology. 2008 Jul 21
• 16 citations
  Perispinal etanercept produces rapid improvement in primary progressive aphasia: identification of a novel, rapidly reversible TNF-mediated pathophysiologic mechanism.
  Edward L Tobinick> ;The Medscape Journal of Medicine. 2008 Jun 10
• A critique of intradiscal administration for treatment of radiculopathy.
  Edward L. Tobinick> ;Anesthesiology. 2008 Feb 1
• 145 citations
  Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration.
  Edward L Tobinick, Hyman Gross> ;Journal of Neuroinflammation. 2008 Jan 9
• 32 citations
  Perispinal Etanercept for Treatment of Alzheimers Disease
  Edward L Tobinick> ;Current Alzheimer Research. 2007 Nov 30
• 2 citations
  Resolution of chronic pain and fingertip ulceration due to hand-arm vibration syndrome following combination pharmacotherapy.
  Catherine Buell, Edward Tobinick, Karen Lamp> ;Archives of Dermatology. 2007 Oct 1
• 5 citations
  Spinal delivery of p38: TNF-alpha inhibitors.
  Edward Tobinick> ;PLOS Medicine. 2006 Nov 28
• 107 citations
  TNF-alpha modulation for treatment of Alzheimer's disease: a 6-month pilot study.
  Edward L Tobinick, Hyman Gross, Alan Weinberger, Hart Cohen> ;MedGenMed : Medscape general medicine. 2006 Apr 26
• 52 citations
  The cerebrospinal venous system: anatomy, physiology, and clinical implications.
  Edward L Tobinick, Charles Vega> ;MedGenMed : Medscape general medicine. 2006 Feb 22
• Join now to see all

Journal Articles

• Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidence.  
  Ignatowski TA, Spengler RN, Dhandapani KM, Folkersma H, Butterworth RF, Tobinick E., CNS Drugs, 8/1/2014
• Authors’ reply to Whitlock: Perispinal etanercept for post-stroke neurological and cognitive dysfunction:scientific rationale and current evidence  
  Ignatowski TA, Spengler RN, CNS Drugs, 1/1/2014
• A neurologist’s guide to TNF biology, and to the principles behind the therapeutic removal of excess TNF in disease  
  Clark, I.A. and B. Vissel, Neural Plasticity, 1/1/2015
• Action of anti-TNF-alpha drugs on the progression of Alzheimer’s disease A case report  
  C.H.F. Camargo, F.F. Justus, G. Retzlaff, M.R.Y. Blood, M.D. Schafranski, Dement Neuropsychol, 1/1/2015
• Transiently lowering tumor necrosis factor-alpha synthesis ameliorates neuronal cell loss and cognitive impairments induced by minimal traumatic brain injury in mice  
  Baratz, R., D. Tweedie, J.Y. Wang, V. Rubovitch, et al., J Neuroinflammation, 1/1/2015
• The hippocampus and TNF: Common links between chronic pain and depression  
  Fasick, V., R.N. Spengler, S. Samankan, N.D. Nader, et al., Neurosci Biobehav Rev, 1/1/2015
• Immune attack: the role of inflammation in Alzheimer disease  
  Heppner, F.L., R.M. Ransohoff, and B. Becher, Nat Rev Neurosci, 1/1/2015
• Effects of systemic Thalidomide and intracerebroventricular Etanercept and Infliximab administration in a Streptozotocin induced dementia model in rats  
  Kubra Elcioglu, H., L. Kabasakal, F. Tufan, O.H. Elcioglu, et al., Acta Histochem, 1/1/2015
• Venous Drainage of the Spine and Spinal Cord: A Comprehensive Review of its History, Embryology, Anatomy, Physiology, and Pathology  
  Griessenauer, C.J., J. Raborn, P. Foreman, M.M. Shoja, M. Loukas and R. Shane Tubbs, Clinical Anatomy, 1/1/2015
• Astrocyte physiopathology: At the crossroads of intercellular networking, inflammation and cell death  
  Rossi, D., Prog Neurobiol, 1/1/2015
• Imaging neuroinflammation in Alzheimer’s and other dementias: Recent advances and future directions  
  Varley, J., D.J. Brooks, and P. Edison, Alzheimers Dement, 1/15/2014
• Tumor Necrosis Factor-alpha Modulates Cerebral Aneurysm Formation and Rupture  
  Starke, R.M., D. Raper, D. Ding, N. Chalouhi, et al., Translational Stroke Research, 1/1/2014
• The common inflammatory etiology of depression and cognitive impairment: a therapeutic target  
  Allison, D.J. and D.S. Ditor, J Neuroinflammation, 1/1/2014
• Drug repositioning: playing dirty to kill pain  
  Bastos, L.F. and M.M. Coelho, CNS Drugs, 1/1/2014
• Targeting TNF: a therapeutic strategy for Alzheimer’s disease  
  Cheng, X., Y. Shen, and R. Li, Drug Discov Today, 1/1/2014
• Systemically administered anti-TNF therapy ameliorates functional outcomes after focal cerebral ischemia  
  Clausen, B., M. Degn, N. Martin, Y. Couch, et al., J Neuroinflammation, 1/1/2014
• Combining select neuropsychological assessment with blood-based biomarkers to detect mild Alzheimer’s disease: a molecular neuropsychology approach  
  Edwards, M., V.H. Balldin, J. Hall, and S. O’Bryant, J Alzheimers Dis, 1/1/2014
• Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer’s disease  
  Ferreira, S.T., J.R. Clarke, T.R. Bomfim, and F.G. De Felice, Alzheimers Dement, 1/1/2014
• Mild cognitive impairment in patients with moderate to severe chronic plaque psoriasis  
  Gisondi, P., F. Sala, F. Alessandrini, V. Avesani, et al., Dermatology, 1/1/2014
• Inhibition of soluble tumor necrosis factor is therapeutic in Huntington’s disease  
  Hsiao, H.Y., F.L. Chiu, C.M. Chen, Y.R. Wu, et al., Hum Mol Genet, 1/1/2014
• Expression levels of tumor necrosis factor-alpha and the corresponding receptors are correlated with trauma severity  
  Liu, C. and J. Tang, Oncol Lett, 1/1/2014
• Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity  
  Olmos, G. and J. Llado, Mediators Inflamm, 1/1/2014
• Peripheral cytokines as a chemical mediator for postconcussion like sickness behaviour in trauma and perioperative patients: literature review  
  Rehman, Y., N. Rehman, and R. Rehman, Neurol Res Int, 1/1/2014
• Cerebral stroke injury: the role of cytokines and brain inflammation  
  Siniscalchi, A., L. Gallelli, G. Malferrari, D. Pirritano, et al., J Basic Clin Physiol Pharmacol, 1/1/2014
• Increased Plasma TACE Activity in Subjects with Mild Cognitive Impairment and Patients with Alzheimer’s Disease  
  Sun, Q., H. Hampel, K. Blennow, S. Lista, et al., J Alzheimers Dis, 1/1/2014
• Join now to see all

Books/Book Chapters

• Skin Surgery, A Practical Guide 
  Usatine R, Tobinick E, Moy R,Siegel DMosby1998
• Translational Neuroscience: Applications in Psychiatry, Neurology, and Neurodevelopmental Disorders 
  Chapter: Chapter 7- Historical perspectives on the discovery and development of drugs to treat neurological disorders 
  Williams, M. and J.T. CoyleEditors: J.E. Barrett, J.T. Coyle, and M. Williams.Cambridge University Press, New York, N.Y.2012
• Encyclopedia of Clinical Neuropsychology 
  Chapter: F-A-S test 
  Patterson, JEditors: J.S. Kreutzer, J. DeLuca, and B. Caplan.Springer Science+Business Media, New York, N.Y.2011
• Cytokines and the Brain 
  Chapter: Cytokines in Synaptic Function 
  Ignatowski, T.A. and R.N. SpenglerEditors: I. Berczi and A. Szentivanyi.Elsevier, Amsterdam, Netherlands2008
• Join now to see all

Abstracts/Posters

• Perispinal TNF-alpha inhibition for discogenic pain
  Tobinick E, 2nd Annual Restauracion Neurologica 2004 International Conference, Havana, Cuba, 1/27/2004
• TNF Modulation for Treatment of Alzheimer’s Disease: Effects on Verbal Function
  Tobinick E, Shirinyan D, Gross H, Days of Molecular Medicine Conference, Karolinska Institutet, Stockholm, Sweden, 1/27/2006
• Perispinal etanercept for Alzheimer’s Disease
  Tobinick E, Restauracion Neurologica 2009 International Conference, Havana, Cuba, 1/11/2009
• Perispinal etanercept produces rapid improvement in primary progressive aphasia
  Tobinick E, 11th International Conference on Alzheimer’s Disease, Chicago, IL, 1/30/2008
• TNF modulation for treatment of Alzheimer’s disease
  Tobinick E, Inaugural Targeting Alzheimer’s with Novel Therapeutics Conference at the World Pharmaceutical Congress, Philadelphia, PA, 1/11/2009
• TNF antagonists for neurological disorders: from concept to the clinic
  Tobinick E, GTC bio’s 5th Modern Drug Discovery & Development Conference, San Diego, CA, 1/14/2009
• Neuroinflammation as a new therapeutic target in neurology
  Tobinick E, Medical Staff CME Lecture, University Hospital, Tamarac, FL, 1/10/2011
• Repurposing of Enbrel for Alzheimer’s Disease
  Tobinick E, Third Annual Drug Repositioning Summit, Boston, MA, 1/6/2008
• Perispinal etanercept for treatment of Alzheimer’s Disease
  Tobinick E, 7th International Conference on Alzheimer’s Disease Drug Discovery; Best Practices in the Continuum of Care: Advances in Alzheimer’s Disease Management conference, University of Arkansas for Medical Sciences, Little Rock, AR, 2008, 1/1/2008
• Join now to see all

Lectures

• TNF inhibition for aphasia after stroke or brain injury 
  Fort Lauderdale, FL - 1/30/2015